Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer

PURPOSE: Triple negative breast cancers (TNBC) frequently have high epidermal growth factor receptor (EGFR) expression and are sensitive to DNA-damaging agents. Improved therapies are needed for this aggressive malignancy. PATIENTS AND METHODS: We performed a phase I trial of bendamustine and erloti...

詳細記述

保存先:
書誌詳細
主要な著者: Layman, Rachel M., Ruppert, Amy S., Lynn, Melinda, Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Lustberg, Maryam B., Wesolowski, Robert, Ottman, Susan, Carothers, Sarah, Bingman, Anissa, Reinbolt, Raquel, Kraut, Eric H., Shapiro, Charles L.
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3710373/
https://ncbi.nlm.nih.gov/pubmed/23430121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2112-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料